ENLV Stock Analysis: Buy, Sell, or Hold?
ENLV - Enlivex Therapeutics Ltd. Ordinary Shares
$0.25
0.00 (-0.45%)
▼
5d:
-30.15%
30d:
-73.65%
90d:
-95.82%
HOLD
LOW Confidence
Analysis Updated: Oct 12, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When ENLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENLV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ENLV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ENLV is currently trading at $0.25, which is considered oversold relative to its 30-day fair value range of $0.38 to $0.94.
Technical Outlook: Technically, ENLV is showing sideways momentum. Immediate support is located at $0.22, while resistance sits at $0.58.
Market Sentiment: ENLV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $80.00 (+31396.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENLV is showing sideways momentum. Immediate support is located at $0.22, while resistance sits at $0.58.
Market Sentiment: ENLV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $80.00 (+31396.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.38 -
$0.94
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31396.1% below Wall St target ($80.00)
- CAUTION: Bottoming setup, but lagging the sector by 80% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-30.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.38 -
$0.94
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$0.58
Current Trend
Sideways
Technical data as of
Oct 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.21
Wall Street Target
$80.00
(+31396.1%)
Share & Embed Analysis
Last updated: October 12, 2026 3:47 PM ET
Data refreshes hourly during market hours. Next update: 4:47 PM
Data refreshes hourly during market hours. Next update: 4:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENLV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$259 | 55 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$73 | 65 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
20 analysts |
$95 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$106 | 49 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 43 HOLD |
